We are on a mission to improve patient care
We would like to introduce the AlgoDx management team. A group of devoted leaders who are passionate about scientific and evidence-based approaches to bring machine learning to healthcare.
Inger Persson
PhD, Sr Lecturer & Researcher, Dept of Statistics at Uppsala University
Director AI & Biostatistics / Co-founder
With over ten years of clinical trials experience from the medtech & pharmaceutical industry with statistical project responsibilities and another decade from university research, Inger brings extensive theoretical skills and know-how on applied statistics. At AlgoDx, she is responsible for AI & biostatistics, which includes multivariate analysis, prediction modelling, time-to-event analysis, machine learning and scientific publications.
David Becedas
M Sc Pharm
CEO / Director Clinical Research / Co-founder
Having spent twenty years working with clinical research, David has a demonstrated track record of leading complex clinical & outcomes research projects. He has previously worked in the pharmaceuticals, medtech & CRO industry, and brings both strong leadership skills and a doer mentality to AlgoDx.
Joakim Söderberg
M Sc Pharm
Director Business Development / Co-founder
Elhabib Moustaid
M Sc Eng, PhD
Chief Technology Officer
A strong academic and engineering background from multiple research and innovation projects. Elhabib is an engineer in Informatics and applied mathematics, a Clinical Innovation Fellow and a Ph.D. in technology at the group of Health Informatics and Logistics in KTH. At AlgoDx, Elhabib is responsible for the design & architecture of our machine learning infrastructure to enable zero-downtime continuous integration of ML algorithms into production settings in healthcare.
Maria Ericson Sandqvist
QA/Operations Manager
After a dozen of years working with clinical research projects in different positions, Maria shifted her focus to work with medical compliance at a global pharmaceutical company. At AlgoDx, Maria is responsible for the implementation of the AlgoDx Quality Management System and for ensuring that project deliverables meet our customers’ expectations.
AlgoDx Board
The AlgoDx Board includes, in addition to the three co-founders the following board members.
Tomas Mora-Morrison
M Sc Engineering
Chairman of the Board
Co-founder of Cambio Healthcare Systems, a leading supplier of healthcare information systems for university hospitals and specialist units on the European market. Currently, Tomas is a member of the Board of Cambio, and he is AlgoDx’s Chairman of the Board.
Erik Gozzi
M Sc Finance
Board Member
Managing partner at Nascent Invest with a broad experience in investing in early stage companies. Erik has board experience from several high-growth companies and has been involved with a several successful exits. Prior to Nascent Invest he worked as an auditor for 10 years at Deloitte in Stockholm.
AlgoDx Advisors
Alistair Bone
Clinical Quality Assurance
Alistair is a seasoned Quality Assurance Consultant with a demonstrated history of working in the pharmaceuticals and medtech industry. In his previous role as Executive VP of QA at TFS, Alistair was responsible for the set-up, development and maintenance of both the TFS CRO global quality assurance department and the TFS Training Academy Programme. Alistair has successfully hosted FDA, EMA, MHRA, and MPA inspections.
Hans Boström
M Sc Pharm, PhD
Regulatory Affairs
Hans has extensive experience within Clinical Operations and Regulatory Affairs from different positions in the Life Science industry. For several years, he has been responsible for Medical and Regulatory Affairs at a Medtech company with the responsibility of securing the clinical documentation and global regulatory clearances for medical device software products.